Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
6.42
+0.09 (1.42%)
May 7, 2026, 4:08 PM HKT
HKG:1167 Market Cap
HKG:1167 has a market cap or net worth of 5.04 billion as of May 7, 2026. Its market cap has increased by 124.23% in one year.
Market Cap
5.04B
Enterprise Value
3.96B
Revenue
59.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.42
Market Cap Chart
Since December 21, 2020, HKG:1167's market cap has decreased from 10.95B to 5.04B, a decrease of -53.98%. That is a compound annual growth rate of -13.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 4.97B | -0.86% |
| Dec 31, 2025 | 5.01B | 400.46% |
| Dec 31, 2024 | 1.00B | -65.05% |
| Dec 29, 2023 | 2.87B | -28.96% |
| Dec 30, 2022 | 4.03B | -63.93% |
| Dec 31, 2021 | 11.19B | 3.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CK Life Sciences Int'l., (Holdings) | 6.92B |
| Guangzhou Innogen Pharmaceutical Group | 6.40B |
| Ocumension Therapeutics | 5.90B |
| Laekna | 5.80B |
| Beijing Luzhu Biotechnology | 4.61B |
| Shandong Boan Biotechnology | 4.38B |
| Qyuns Therapeutics | 3.86B |
| BioDlink International Company | 3.83B |